Racial and Ethnic Diversity in FDA Regulated Clinical Trials
Artificial intelligence has been in the spotlight recently, but it is not a new concept to the Food and Drug Administration (FDA) or the medtech industry. AI advancements in the…
Learn more about our Health Equity work.
Artificial intelligence has been in the spotlight recently, but it is not a new concept to the Food and Drug Administration (FDA) or the medtech industry. AI advancements in the…
AdvaMed is dedicated to ensuring our industry focuses their efforts on treating and raising the awareness of women’s health conditions.
The final report of a three-part series investigates the prevalence of racial and ethnic disparities in the use of in the use of advanced interventions in the Medicare program.
The second of a three-phase research series examines the difference in access to certain advanced interventions, including a range of surgical, medical and technological interventions.
Racial and ethnic healthcare disparities in access to advanced interventions have persisted in the U.S. medical system. The first of a three-phase research series examines the difference in access to…
This February, AdvaMed is working with member companies and our global partners to raise awareness and highlight the ways medical technology helps those living with cardiovascular disease live healthier, happier…
MIDI describes recent advancements their team engineered in the biopharma fabrication space.
AdvaMed, the medtech association, today released the following statements on the White House’s announcement today of a new initiative focused on women’s health research to be led by First Lady…
We are committed to ensuring that our mission is not compromised by the perpetuation of racial health disparities.
This year marks the 20th anniversary of the landmark Unequal Treatment report from the Institute of Medicine (now the National Academies of Medicine). Unequal Treatment put a spotlight on the…